Multiple Manufacturers

ETOPOPHOS

Manufacturer:

Multiple Manufacturers

Etopophos HCPCS:

J9181

HCPCS Code Descriptor:

Injection, etoposide, 10 mg

Category:

J Code

Etopophos NDCs:

16729-0262-31, 00143-9510-01, 00143-9376-01, 68001-0265-25, 16729-0114-31, 00703-5656-01, 00143-9511-01, 16729-0114-08, 68001-0265-26, 68001-0265-27, 00143-9512-01, 63323-0104-25, 16729-0114-11, 63323-0104-50, 00015-3404-20, 63323-0104-05, 61269-0410-20

Primary Type:

Oncology

Generic/Specialty Status:

Multi-Source

Package Type:

Vial

Route of Administration:

Intravenous

Potential NDC Listing Errors:

Our team has identified potential listing errors/discrepancies with the following NDCs:

16729-0262-31, 00015-3404-20, 63323-0104-05

About Etopophos:

ETOPOPHOS is a medication manufactured by multiple manufacturers and aligned to the J Code: J9181. ETOPOPHOS is administered via the intravenous route of administration.

ACCESS PRICING AND MORE BY REGISTERING

J9181 Added Date:

January 1, 1987

J9181 Effective Date:

January 1, 2009

J9181 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Etopophos billing and coding information.
Our team did not identify a source for Etopophos patient assistance information. Please reach out to our team if you feel that this is a mistake.
ETOPOPHOS prescribing information can be found at the link below. Please reach out to us if you believe this information to be innacurate or out of date.
Our team has not yet identified a source of side effects information for ETOPOPHOS. Please check back in a few weeks.